Human MIP-1 alpha (CCL3) Recombinant
$70.00 – $2,700.00
accession | P10147 |
Source | Optimized DNA sequence encoding Human MIP-1 alpha mature chain was expressed in Escherichia Coli. |
Molecular weight | Native human MIP-1 alpha is generated by the proteolytic removal of the signal peptide.This molecule has a calculated molecular mass of approximately 8 kDa. Recombinant MIP-1 alpha is a monomer protein consisting of 70 amino acid residue subunits, and migrates as an approximately8 kDa protein under non-reducing and reducing conditions in SDS-PAGE. |
Purity | >98%, as determined by SDS-PAGE and HPLC |
Biological Activity | Determined by its ability to chemoattract human monocytes using a concentration range of.0-10.0 ng/ml. |
Protein Sequence | MQVSTAALAV LLCTMALCNQ FSASLAADTP TACCFSYTSR QIPQNFIADY FETSSQCSKP GVIFLTKRSR QVCADPSEEW VQKYVSDLEL SA |
Endotoxin | Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than.1 ng/µg(1EU/µg). |
Presentation | Recombinant MIP-1 was lyophilized from a.2 μm filtered PBS solution pH7.5. |
Reconstitution | A quick spin of the vial followed by reconstitution in distilled water to a concentration not less than.1 mg/mL. This solution can then be diluted into other buffers. |
Storage | The lyophilized protein is stable for at least years from date of receipt at -20° C. Upon reconstitution, this cytokine can be stored in working aliquots at° -° C for one month, or at -20° C for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles. |
Usage | This cytokine product is for research purposes only.It may not be used for therapeutics or diagnostic purposes. |
Interactor | P32302 |
Interactor | P32246 |
Interactor | P51677 |
Interactor | P51681 |
Biological Process | Chemotaxis |
Biological Process | Inflammatory-response |
Molecular function | Cytokine |